Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-014838

President and CEO sold 716 shares at $10.59 ($7,582)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
AHMED NADIM President and CEO 2023-04-25 Sale −716 $10.59 $7,582 117,288 D: show line 1 in the form
Open-market sales · 716 sh · avg $10.59 · $7,582
Loading xslF345X04/ownership.xml…